Benitec Biopharma Inc
For the period ended Mar 31, 2024. Filed May 13, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 13, 2024
BNTC$9.87+3.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| Item 6. | Exhibits. |
|---|
| Number | Description of Document |
| 4.1 | Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.1 to the Company’s Form 8-K filed on April 19, 2024 (File. No. 001-39267)) |
| 10.1 | Securities Purchase Agreement, dated April 17, 2024, by and among Benitec Biopharma Inc. and each purchaser identified on the signature pages thereto (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on April 19, 2024 (File. No. 001-39267)) |
| 10.2 | Registration Rights Agreement, dated April 22, 2024, by and between Benitec Biopharma Inc. and each of the purchasers signatory thereto* |
| 10.3 | Form of Voting Commitment Agreement (incorporated by reference to Exhibit 10.3 to the Company’s Form 8-K filed on April 19, 2024 (File. No. 001-39267)) |
| 10.4 | Board Designation Agreement, dated April 22, 2024, by and between Benitec Biopharma Inc. and Suvretta Capital Management, LLC* |
| 31.1 | Statement of CEO Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002* |
| 31.2 | Statement of CFO Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002* |
| 32.1 | Statement of CEO Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002** |
| 32.2 | Statement of CFO Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002** |
| 101.INS | Inline XBRL Instance Document* |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document* |
| 101.CAL | Inline XBRL Calculation Linkbase Document* |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document* |
| 101.LAB | Inline XBRL Label Linkbase Document* |
| 101.PRE | Inline XBRL Taxonomy Presentation Linkbase Document* |
| 104 | Cover Page Interactive Data File—the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
| * | Filed herewith. |
|---|
| ** | Furnished, not filed. |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.